<DOC>
	<DOCNO>NCT03005288</DOCNO>
	<brief_summary>This study ass safety , pharmacokinetics efficacy bimagrumab administer obese patient type 2 diabetes</brief_summary>
	<brief_title>Safety , Pharmacokinetics Efficacy Bimagrumab Obese Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Antibodies , Blocking</mesh_term>
	<criteria>Type 2 diabetes HbA1c 7 % 10 % screen stable treatment 3 month prior randomization Body Mass Index 28 40 kg/m2 screen Body weight 65 140 kg screen Women childbearing potential unless use highly effective method contraception Diabetes Type 2 Type 1 diabetes , surgically induced diabetes , `` brittle '' type 2 diabetes per investigator judgement , history severe hypoglycemic episode year precede screen hypoglycemic unawareness history clinically significant arrythmias , unstable angina , myocardial infarction stroke , coronary artery bypass graft surgery , percutaneous coronary intervention within 6 month screen 1 year drugeluting stent use antiobesity medication , nutritional supplement counter product ofr weight loss within 3 month screen use medication know induce weight gain anticonvulsant psychotropic medication within 3 month screen Any chronic active infection ( e.g. , HIV , Hepatitis B C , tuberculosis , etc ) . uncontrolled thyroid disease . Stable euthyroid patient stable thyroid replacement therapy least 3 month screen allow . Known history presence severe active acute chronic liver disease ( e.g. , cirrhosis ) Uncontrolled depression Use skeletal muscle anabolic agent form 3 month prior screen Chronic kidney disease [ estimate glomerular filtration rate ( GFR ) &lt; 30 mL/min ] ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>obesity</keyword>
	<keyword>DXA</keyword>
	<keyword>MRI</keyword>
</DOC>